Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial. (nature.com)

Authors: Yu M … Xiao X Journal: Nature Medicine Published: 2026-09-29 DOI: https://doi.org/10.1038/s41591-026-04651-9